LDPath

Dr Paul Craig is a Consultant Dermatopathologist with a long experience in private practice and has reported digitally for LDPath (now SourceLDPath) since its inception 13 years ago with excellent turnaround times, and values close working relationships with clinicians including with private MDT meetings.
He is an Honorary Consultant at Gloucestershire Hospitals NHSFT and formerly at North Bristol and University Hospitals Bristol NHST, and Fremantle Hospital, Western Australia.
He trained at Barts and The Royal London and as Fellow in Dermatopathology at St. John’s Institute of Dermatology obtaining the expert referral level RCPath Diploma in Dermatopathology & subsequently has been an examiner for this for 15 years.
Past President of British Society for Dermatopathology 2014-17 and lead organiser & Chair of Glasgow 2017 International Society of Dermatopathology Symposium.
He has interests in tumour dermatopathology (including keratinocyte cancers and melanocytic lesions) and inflammatory dermatopathology with a long term NHS expert referral dermatopathology practice, and lectures and teaches nationally and internationally.
Current roles:
- RCPath Dermatopathology Subcommittee (chair 2021-2025)
- Pathology lead, UK Keratinocyte Collaborative of British Association of Dermatologists for cutaneous skin cancer research, & trial management group SCC-AFTER NIHR skin cancer trial
- Member, British Association of Dermatologists Skin Cancer Services Group guidelines
- Co-author, (in draft 2026) RCPath Dataset: Cutaneous Squamous Cell Carcinoma
- Member, UK National Specialist Dermatopathology External Quality Assurance Steering Committee Advisory Group
- Member Test Evaluation Working Group for National Genomic Test Directory for Cancer, Genomics Medicine Service, NHS England
Dr Paul Craig DipDerm FRCPath FRCPA, Consultant Histopathologist & Dermatopathologist
The LDPath group provide a first class pathology reporting, with rapid turnaround of cases, secure reporting and second opinion service using international experts when needed. They are always available when needing to discuss complex cases, which is why I have insisted on only using them for my cases.
